Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS)

M. Stahl (Heidelberg, Germany), M. Wielpuetz (Heidelberg, Germany), I. Ricklefs (Lübeck, Germany), S. Graeber (Heidelberg, Germany), O. Sommerburg (Heidelberg, Germany), G. Diekmann (Lübeck, Germany), C. Dopfer (Hannover, Germany), S. Barth (Giessen, Germany), A. Schlegtendal (Bochum, Germany), C. Koerner-Rettberg (Bochum, Germany), L. Naehrlich (Giessen, Germany), B. Tuemmler (Hannover, Germany), M. Kopp (Lübeck, Germany), M. Mall (Heidelberg, Germany)

Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Session: Cystic fibrosis: microbiological aspects and new treatments
Session type: Oral Presentation
Number: 513
Disease area: Paediatric lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Stahl (Heidelberg, Germany), M. Wielpuetz (Heidelberg, Germany), I. Ricklefs (Lübeck, Germany), S. Graeber (Heidelberg, Germany), O. Sommerburg (Heidelberg, Germany), G. Diekmann (Lübeck, Germany), C. Dopfer (Hannover, Germany), S. Barth (Giessen, Germany), A. Schlegtendal (Bochum, Germany), C. Koerner-Rettberg (Bochum, Germany), L. Naehrlich (Giessen, Germany), B. Tuemmler (Hannover, Germany), M. Kopp (Lübeck, Germany), M. Mall (Heidelberg, Germany). Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS). 513

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: